CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GEN - Genetic Engineering & Biotech News
Original article

AstraZeneca Licenses Global Rights to Dizal Lung Cancer Drug for Up-to-$1.5B

Related Companies

Read the original article

Published by GEN - Genetic Engineering & Biotech News on July 15, 2026 1:45 AM

Read Original